Sun Pharmaceutical Industries Ltd. has divulged incretin analogues acting as dual agonists of gastric inhibitory polypeptide (GIPR) receptor/GLP-1 or GLP-1/glucagon receptor (GCGR) or triple agonists ...
There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.
Gut hormones that influence satiety, such as peptide YY (PYY ... change after Roux-en-Y gastric bypass. Le Roux et al. measured fasting and postprandial levels of PYY, GLP-1 and ghrelin before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback